**Specifications table**TableSubject areaClinical immunologyMore specific subject areaAsthma in younger childhoodType of dataTable and FigureHow data was acquiredClinical examinationData formatAnalysedExperimental factorsAsthma prognosis factor on each ageExperimental featuresNasal eosinophil positive rates in childhood asthma increased according to age raised.Data source locationOsaka, JapanData accessibilityThe data are supplied with this articleRelated research articleDissecting childhood asthma with nasal transcriptomics distinguishes subphenotypes of disease. Poole A et al. J Allergy Clin Immunol. (2014).Childhood asthma control test (C-ACT) and nasal eosinophil inflammation in asthmatic children. Piacentini GL et al. Allergy. (2010)Virus detection and cytokine profile in relation to age among acute exacerbations of childhood asthma. Kato M et al. Allergol Int. (2015)

**Value of the data**•Nasal eosinophil positive rates with asthma symptoms increased by age raised.•Nasal eosinophil positive rates without asthma symptoms did not increase by age raised.•Nasal eosinophil positive have significant relationship with specific IgE positive and other allergic disease positive. It is easy to examine and low cost.•Testing for nasal discharge eosinophils is easy and inexpensive, and similar to other predictive factors, with higher positive rates in older age groups. Moreover, a correlation was observed between nasal discharge eosinophils and other allergic disease markers (RAST positivity and coexisting diseases).

1. Data {#s0005}
=======

1.1. Patients ([Table 1](#t0005){ref-type="table"}.) {#s0010}
----------------------------------------------------

This data article included patients treated at Murayama Pediatrics with recurrent episodes of symptoms respiratory symptoms such as coughing, wheezing and dyspnea at least 3 recurrent episodes. And more than three times improvement using bronchodilator inhalation at intervals of ≥ 1 week. According to the Japanese guidelines for child asthma [@bib1], which attaches importance for the early intervention of infant or child asthma, these patients were divided into an asthma group (A group) and a non-asthma group (NA group). A total of 180 patients showed nasal symptoms, such as nasal discharge for ≥ 1 week, without fever, being in 85 patients in the A group and 95 patients in the NA group.

1.2. Nasal eosinophil examination ([Table 2](#t0010){ref-type="table"}) {#s0015}
-----------------------------------------------------------------------

Distribution of nasal discharge eosinophil counts in both data groups. The nasal discharge eosinophil counts in the entire cohort were: negative (−) in 60% of patients; +− in 12.9%; 1+ in 20.0%; 2+ in 2.3%; and 3+ in 4.7%. Most of the positive data were graded as either +− or +.

2. Experimental design, materials and methods {#s0020}
=============================================

2.1. Experimental design and statistical analysis {#s0025}
-------------------------------------------------

Nasal eosinophil examination is routine test of allergic rhinitis, continued symptoms of nasal discharge without fever up. The data were pooled at Murayama Pediatrics from August to December 2008. This data were approved by the staff of Maruyama Pediatrics. Informed consent was received orally or in written form from all patients and/or their guardians. Using these data we investigated that nasal eosinophil can be a prognosis factor as well as allergic family history, coexisting other allergic diseases, IgEs and eosinophil in peripheral blood.

Statistical analysis using the chi-square test was performed with JSTAT for Windows version 17.1.

2.2. Material and methods {#s0030}
-------------------------

To examine that nasal eosinophil is a prognosis factor for persistent asthma, the pooled data were divided two groups according to with or without asthma symptoms by each age. We investigated that nasal eosinophil positive rates in asthma and non-asthma group by each age. Moreover we compared relationship of nasal eosinophil positive rates pattern with other prognosis factors.

2.3. With (A group) and without (NA group) asthma symptoms nasal eosinophil positive rates by each age ([Fig. 1](#f0005){ref-type="fig"}.) {#s0035}
------------------------------------------------------------------------------------------------------------------------------------------

The positive nasal discharge eosinophil rates according to age in the A group were: age 0--1 years, 14.3% (4/28); age 2--3 years, 47.8% (11/23); age 4--5 years, 42.1% (8/19) and age ≥ 6 years, 73.3% (11/15). The positive nasal discharge eosinophil rates increased with increasing age, the positive nasal discharge eosinophil rates in the A group were significantly higher for patients aged 2--3 years, 4--5 years, and ≥ 6 years than in patients aged 0--1 years (*p*\< 0.05--0.001, chi-square test). Meanwhile, the positive nasal discharge eosinophil rates according to age in the NA group were approximately the same across all age groups (approximately 30% in each age group).

2.4. With (A group) and without (NA group) asthma symptoms IgE RAST positive rates by each age ([Fig. 2](#f0010){ref-type="fig"}.) {#s0040}
----------------------------------------------------------------------------------------------------------------------------------

The RAST-positive rates, according to age, are shown in [Fig. 2](#f0010){ref-type="fig"}. The RAST reactions were positive (\> 0.35 UA) mainly for egg whites, *Dermatophagoides farinae*, and cat skin scraps. The positive RAST rates according to age in the A group were age 0--1 years 21.4% (6/28), age 2--3 years 43.5% (10/23), age 4--5 years 42.1% (8/19) and age ≥ 6 years 93.3% (14/15). These positive RAST rates was significantly higher in the age ≥ 6 years groups than in the 0--1-year-old age group (*p*\< 0.001). The positive age-based RAST rates in the NA group were approximately 0--10% overall and did not differ significantly between each age group. According to each age group, the RAST-positive rates on A group were significantly higher than those of NA group (*p*\< 0.05--0.001).Fig. 1Nasal discharge eosinophils by age. A, Asthma group; NA, Non-asthma group. The positive nasal discharge eosinophil rates in the A group were significantly higher in patients aged 2--3 years, 4--5 years, and ≥ 6 years than in patients aged 0--1 years (*p*\< 0.05-0.001, chi-square test).Fig. 1Fig. 2RAST-positive rates by age. A, Asthma group; NA, Non-asthma group. Positive RAST rates were significantly higher in the older age groups than in the 0--1-year-old age group (NS, *p*\< 0.01).Fig. 2

2.5. With (A group) and without (NA group) asthma symptoms family history rates by each age ([Fig. 3](#f0015){ref-type="fig"}.) {#s0045}
-------------------------------------------------------------------------------------------------------------------------------

The positive allergic family history rates, according to age, are shown in [Fig. 3](#f0015){ref-type="fig"}. The positive allergic family history rates, according to age, in the A group were age 0--1 years 17.9% (5/28), age 2--3 years 43.5% (10/23), age 4--5 years 31.6% (6/19) and age ≥ 6 years 66.7% (10/15). These positive allergic family history rates were significantly higher in the older age groups than in the 0--1-year-old age group (NS, *p*\< 0.01). The positive allergic family history rates in the NA group were approximately 20% overall and did not differ significantly by age group. For each age group, the positive allergic family history rates of A group were higher than those of age matched NA group (NS, *p*\< 0.01), except for the 0--1-years-old age group.Fig. 3Positive allergic family history rates according to age group. A, Asthma group; NA, Non-asthma group. Positive allergic family history rates were significantly higher in the older age groups than in the 0--1-year-old age group (NS, *p*\< 0.01).Fig. 3

2.6. With (A group) and without (NA group) asthma symptoms coexisting other allergic diseases rates by each age ([Fig. 4](#f0020){ref-type="fig"}.) {#s0050}
---------------------------------------------------------------------------------------------------------------------------------------------------

The positive rates of coexisting or past allergic diseases (eczema, allergic conjunctivitis) are shown in [Fig. 4](#f0020){ref-type="fig"}. The positive coexisting allergic disease (other than asthma) rates in the A group were age 0--1 years 10.7% (3/28), age 2--3 years 26.1% (6/23), age 4--5 years 31.6% (6/19) and age ≥ 6 years 53.3% (8/15). The other coexisting allergic diseases rates were significantly higher in age ≥ 6 years, but not significant in any other older age group, when compared to the 0--1-year-old age group (*p*\< 0.01) ([Fig. 5](#f0025){ref-type="fig"}, [Fig. 6](#f0030){ref-type="fig"}).Fig. 4Positive coexisting or past allergic diseases rates (eczema, allergic conjunctivitis). A, asthma group; NA, Non-asthma group. The rates of coexisting allergic diseases were significantly higher in the older age groups than in the 0--1-year-old age group (NS, *p*\< 0.01).Fig. 4Fig. 5Murayama Pediatrics, Since 1994, Osaka, Japan. This is our Murayama Pediatric Clinic. In this clinic all nasal eosinophil data were gathered.Fig. 5Fig. 6Prognosis of childhood asthma. Some infant asthma grow up to persistent asthma by age raised. The other infant asthma grow up to asthma symptoms free by age raised. Prognosis (predictive) factors play an important roles weather asthma symptoms are persistent or free.Fig. 6

2.7. Correlation nasal eosinophil and other prospective factors in group A ([Table 3](#t0015){ref-type="table"}.) {#s0055}
-----------------------------------------------------------------------------------------------------------------

Each of the above 4 assessments in the A group showed significantly higher positive rates in each age group older than the 0--1-year-old age group. On the other hand, each of the above assessments in the NA group showed similar positive rates across all age groups, without significant differences. According to each age group, the positive rates of allergic family history rates on A group were not significantly different, when compared with those of the NA group.

Correlations between nasal discharge eosinophils and other predictive factors in the A group are presented in [Table 3](#t0015){ref-type="table"}. In the A group, no significant correlation was observed between nasal discharge eosinophils and an allergic family history. However, significant correlations were observed between nasal discharge eosinophils and the RAST data (*p*\< 0.01), as well as other coexisting or past allergic diseases (*p*\< 0.05). In other words, positive nasal discharge eosinophil rates were significantly correlated with RAST positivity and the presence of coexisting or past allergic diseases.Table 1The number of patients in each age group.Table 1Age (*y*)0--12--34--5\> 6SumTotalAsthma2823191585180No Asthma483011695(M: 94, F: 86)Table 2Nasal eosinophil counts for each group.Table 2Eosinophil count0\< 5/10F5--50/10F50--100/10F\>100/10FBy microscope (400×)+-++++++Asthma (%)60.012.920.02.34.7No Asthma (%)69.416.811.61.11.1[^1]Table 3Match correlations between nasal eosinophils and other predictive features.Table 3A groupRAST Number of patientsFamily Number of patientsOther Allergy Number of patientsNegativePositiveNegativePositiveNegativePositiveNasal eosinophil (+)1123[\*\*](#tbl3fnStarStar){ref-type="table-fn"}18162014[\*](#tbl3fnStar){ref-type="table-fn"}Nasal eosinophil (-)36153615429RAST Number of patientsFamily Number of patientsOther Allergy Number of patients              NA groupNegativePositiveNegativePositiveNegativePositiveNasal eosinophil (+)272236245Nasal eosinophil (-)6245412606[^2][^3][^4]

Transparency document. Supplementary material {#s0075}
=============================================

Supplementary material.

I wish to thank all staffs for their advice and cooperation for these data.

Data accessibility; Data are available with this article.

Ethical statement {#s0065}
=================

This study was exempt from ethics committee approval due to the study being retrospective. However, we included two nurses who received ethics education under the Helsinki Declaration through lectures by the branching congress of the Japanese Pediatrics Society and Allergy Society 2--3 times per year.

Transparency data associated with this article can be found in the online version at <https://doi.org/10.1016/j.dib.2018.09.018>.

[^1]: An eosinophil count 0/10 F was considered negative, and eosinophil counts greater than 1/10 F were considered positive.

[^2]: A, Asthma group; NA, Non-asthma group; Family, Atopic family history; Other, Other allergic diseases.

[^3]: *p*\< 0.05,

[^4]: *p*\< 0.01, Chi-squared test.
